OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Enhanced Sampling Approach to the Induced-Fit Docking Problem in Protein–Ligand Binding: The Case of Mono-ADP-Ribosylation Hydrolase Inhibitors
Qianqian Zhao, Riccardo Capelli, Paolo Carloni, et al.
Journal of Chemical Theory and Computation (2021) Vol. 17, Iss. 12, pp. 7899-7911
Open Access | Times Cited: 21

Showing 21 citing articles:

Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2
Stefan Gahbauer, G.J. Correy, M. Schuller, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 2
Open Access | Times Cited: 90

Fragment‐based drug discovery—the importance of high‐quality molecule libraries
Marta Bon, Alan Bilsland, Justin Bower, et al.
Molecular Oncology (2022) Vol. 16, Iss. 21, pp. 3761-3777
Open Access | Times Cited: 76

Computational Modeling of Pharmaceuticals with an Emphasis on Crossing the Blood–Brain Barrier
Patrícia Alencar Alves, Luana Cristina Camargo, Gabriel Souza, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 217-217
Open Access | Times Cited: 1

Towards design of drugs and delivery systems with the Martini coarse-grained model
Lisbeth R. Kjølbye, Gilberto P. Pereira, Alessio Bartocci, et al.
QRB Discovery (2022) Vol. 3
Open Access | Times Cited: 29

Targeting in silico GPCR conformations with ultra-large library screening for hit discovery
Davide Sala, Hossein Batebi, Kaitlyn V. Ledwitch, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 3, pp. 150-161
Open Access | Times Cited: 12

Computation of Protein–Ligand Binding Free Energies with a Quantum Mechanics-Based Mining Minima Algorithm
Megan Schlinsog, Tosaporn Sattasathuchana, Peng Xu, et al.
Journal of Chemical Theory and Computation (2025)
Open Access

Identification of a new Small Rho GTPase Inhibitor Effective in Glioblastoma Human Cells
Angela Parise, Ivana Manini, Enrico Pobega, et al.
European Journal of Medicinal Chemistry (2025), pp. 117704-117704
Closed Access

Computer simulation of molecular recognition in biomolecular system: from in silico screening to generalized ensembles
Yoshifumi Fukunishi, Junichi Higo, Kota Kasahara
Biophysical Reviews (2022) Vol. 14, Iss. 6, pp. 1423-1447
Open Access | Times Cited: 12

Exploring Product Release from Yeast Cytosine Deaminase with Metadynamics
Kayla A. Croney, James McCarty
The Journal of Physical Chemistry B (2024) Vol. 128, Iss. 13, pp. 3102-3112
Open Access | Times Cited: 2

Assessing the Binding Mode of a Splicing Modulator Stimulating Pre-mRNA Binding to the Plastic U2AF2 Splicing Factor
Riccardo Rozza, Pavel Janoš, Alessandra Magistrato
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 23, pp. 7508-7517
Closed Access | Times Cited: 5

Interface-driven structural evolution on diltiazem as novel uPAR inhibitors: from in silico design to in vitro evaluation
Song Xie, Yang Zhou, Hao Zhu, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 1

Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 Macrodomain of SARS-CoV-2
Stefan Gahbauer, G.J. Correy, M. Schuller, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6

Identification of antiparasitic drug targets using a multi-omics workflow in the acanthocephalan model
Hanno Schmidt, Katharina Mauer, Manuel Glaser, et al.
BMC Genomics (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 5

In silico -based screening of natural products as potential inhibitors of SARS-CoV-2 macrodomain 1
Song Xie, Shoujing Cao, Juhong Wu, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 10, pp. 5229-5237
Closed Access | Times Cited: 2

Multiple Poses and Thermodynamics of Ligands Targeting Protein Surfaces: The Case of Furosemide Binding to mitoNEET in Aqueous Solution
Gia Linh Hoang, Jonas Goßen, Riccardo Capelli, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 4

Molecular Docking: An Emerging Tool for Target-Based Cancer Therapy
Pavithra Uppathi, Suraj Rajakumari, K. V. Saritha
Critical Reviews™ in Oncogenesis (2024) Vol. 30, Iss. 1, pp. 1-13
Closed Access

NAD+ Consuming Enzymes: Involvement in Therapies and Prevention of Human Diseases
Mitsuko Masutani, Masanao Miwa, Palmiro Poltronieri
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 12, pp. 1351-1354
Closed Access | Times Cited: 1

Page 1

Scroll to top